4 Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243–51.
12 Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.
19 Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.
38 Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020;396(10245):199–212.
47 Singer M, Glynne P. Treating critical illness: the importance of first doing no harm. PLoS Med. 2005;2(6):e167.
1 Stuby J, Rudiger A. Die vier Schockformen – Teil 1. Swiss Med Forum. 2022;22(21–22):344–348.
2 Monnet X, Teboul J-L. Passive leg raising: five rules, not a drop of fluid! : Springer; 2015.
3 Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. Jama. 2012;308(15):1566–72.
4 Myburgh JA, Mythen MG. Resuscitation fluids. New England Journal of Medicine. 2013;369(13):1243–51.
5 Yunos NaM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Critical care medicine. 2011;39(11):2419–24.
6 Bayer O, Reinhart K, Kohl M, Kabisch B, Marshall J, Sakr Y, et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Critical care medicine. 2012;40(9):2543–51.
7 Hauffe T, Krüger B, Bettex D, Rudiger A. Shock management for cardio-surgical ICU patients–the golden hours. Cardiac failure review. 2015;1(2):75.
8 Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine. 2012;367(20):1901–11.
9 Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. Jama. 2013;309(7):678–88.
10 Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Critical care medicine. 2011;39(6):1335–42.
11. Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive care medicine. 2009;35(9):1539–47.
12 Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine. 2001;345(19):1368–77.
13 Scheeren TW, Bakker J, Kaufmann T, Annane D, Asfar P, Boerma EC, et al. Current use of inotropes in circulatory shock. Annals of intensive care. 2021;11(1):1–13.
14 Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, et al. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Cardiac failure review. 2020;6.
15 Asfar P, Teboul J-L, Radermacher P. High versus low blood-pressure target in septic shock. The New England journal of medicine. 2014;371(3):283–4.
16 Vincent J-L, De Backer D. Circulatory shock. New England Journal of Medicine. 2013;369(18):1726–34.
17 Asfar P, Meziani F, Hamel J-F, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583–93.
18 Monnet X, Jabot J, Maizel J, Richard C, Teboul J-L. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Read Online: Critical Care Medicine| Society of Critical Care Medicine. 2011;39(4):689–94.
19 Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive care medicine. 2017;43(3):304–77.
20 Chow JH, Abuelkasem E, Sankova S, Henderson RA, Mazzeffi MA, Tanaka KA. Reversal of vasodilatory shock: current perspectives on conventional, rescue, and emerging vasoactive agents for the treatment of shock. Anesthesia & Analgesia. 2020;130(1):15–30.
21 Rudiger A, Singer M. Decatecholaminisation during sepsis. BioMed Central; 2016.
22 Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. New England Journal of Medicine. 2008;358(9):877–87.
23 Harjola VP, Mebazaa A, Čelutkienė J, Bettex D, Bueno H, Chioncel O, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. European journal of heart failure. 2016;18(3):226–41.
24 Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. British journal of haematology. 2013;160(4):445–64.
25 Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or restrictive transfusion after cardiac surgery. New England Journal of Medicine. 2015;372(11):997–1008.
26 Hajjar LA, Vincent J-L, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. Jama. 2010;304(14):1559–67.
27 Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine. 2011;365(26):2453–62.
28 Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion strategies for patients in pediatric intensive care units. New England Journal of Medicine. 2007;356(16):1609–19.
29 Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117(5):686–97.
30 Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. Jama. 2006;295(21):2511–5.
31 Pöss J, Vollert J, Böhm M, Thiele H, Hamm C, Leick J, et al. Infarktbedingter kardiogener Schock. Der Kardiologe. 2014;8(4):302–12.
32 Werdan K, Ruß M, Buerke M, Engelmann L, Ferrari M, Friedrich I, et al. Deutsch-österreichische S3-Leitlinie Infarktbedingter kardiogener Schock―: Diagnose, Monitoring und Therapie. Intensivmedizin+ Notfallmedizin. 2011;48(4):291–344.
33 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2021;42(36):3599–726.
34 Jardin F, Vieillard-Baron A. Is there a safe plateau pressure in ARDS? The right heart only knows. Intensive care medicine. 2007;33(3):444–7.
35 Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Applied Physiology in Intensive Care Medicine: Springer; 2006. p. 207–15.
36 Arrigo M, Jaeger N, Seifert B, Spahn DR, Bettex D, Rudiger A. Disappointing success of electrical cardioversion for new-onset atrial fibrillation in cardiosurgical ICU patients. Critical care medicine. 2015;43(11):2354–9.
37 Saxena A, Garan AR, Kapur NK, O’Neill WW, Lindenfeld J, Pinney SP, et al. Value of hemodynamic monitoring in patients with cardiogenic shock undergoing mechanical circulatory support. Circulation. 2020;141(14):1184–97.
38 Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. The Lancet. 2020;396(10245):199–212.
39 Wilhelm MJ, Inderbitzin DT, Reser D, Halbe M, Van Tillburg K, Albrecht R, et al. Outcome of inter-hospital transfer of patients on extracorporeal membrane oxygenation in Switzerland. Swiss medical weekly. 2019;149:w20054.
40 Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical care medicine. 2006;34(6):1589–96.
41 Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. New England Journal of Medicine. 2015;372(14):1301–11.
42 Investigators A, Group tACT. Goal-directed resuscitation for patients with early septic shock. New England Journal of Medicine. 2014;371(16):1496–506.
43 Investigators P. A randomized trial of protocol-based care for early septic shock. New England Journal of Medicine. 2014;370(18):1683–93.
44 Angus DC, Barnato A, Bell D, Bellomo R, Chong C-R, Coats TJ, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive care medicine. 2015;41(9):1549-–60.
45 Singer M. Sepsis: personalization v protocolization? Critical Care. 2019;23(1):1–6.
46 Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Read Online: Critical Care Medicine | Society of Critical Care Medicine. 2013;41(2):580–637.
47 Singer M, Glynne P. Treating critical illness: the importance of first doing no harm. PLoS medicine. 2005;2(6).
48 Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive care medicine. 2018;44(6):925–8.